BAYER has announced the planned net reduction of about 2000 jobs across its global operations - or about 2% of its total staff - to focus resources on “growth and innovation”. The company is aiming to save €800m a year from 2013, with 4500 existing positions gone but another 2500 new jobs created over the same period, mostly in emerging markets. Chairman Marijn Dekkers said about half of the savings would be reinvested in Bayer’s development pipeline and marketing, with the move necessitated because “sales and earnings are under pressure from generic products, rising development costs and the effects of health care reforms”.
The above article was sent to subscribers in Pharmacy Daily's issue from 19 Nov 10
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Nov 10
